جستجوی استاد راهنمای دانشگاهی

Kristel Bernaerts is a Professor at KU Leuven's Faculty of Engineering Sciences within the Department of Chemical Engineering, leading research in Chemical and Biochemical Reactor Technology and Safety (CREaS). She serves as Program Director for POC Safety Engineering and holds multiple leadership roles including membership in the Faculty Council of Engineering Sciences and the Committee for Prevention and Protection at Work. Faculty of Engineering Sciences Chemical and Biochemical Reactor Technology and Safety (CREaS) iSi Health - KU Leuven Institute for Physics-based Modeling Her research focuses on microbial biotechnology with emphasis on oral microbiome engineering, biofilm dynamics, and chemical process safety. Key areas include probiotic delivery systems for periodontal treatment, microbial reactor optimization, and safety engineering for biological products. She develops innovative technologies like slow-release devices for oral probiotics and electrospinning-based encapsulation methods. Recent publications reveal strong trends in oral biofilm modulation (65% of 2023-2025 works), microbial community engineering (25%), and safety/risk analysis (10%). Her work bridges fundamental microbial ecology with clinical applications, particularly in periodontitis treatment and probiotic delivery. As an active supervisor, she mentors PhD candidates including Loverdou, N. and Bäcker, L.E. across interdisciplinary projects spanning chemical engineering, dentistry, and synthetic biology. Her current €15M+ research portfolio includes: EU-funded MICROTUNe platform for bioprocess optimization (2024-2030) Probiotic dry toothpaste development (2024-2027) Wood-eating beetle microbiome valorization (2023-2027) AI-driven antivirulent protein design (2024-2028) She leads the POC Safety Engineering program and contributes to chemical engineering education through courses on process safety, reactor engineering, and analytical chemistry.

• Microbial Biotechnology
• Oral Microbiome Engineering
• Biofilm Dynamics
• +۳ مورد دیگر

Johannes Swinnen is a Full Professor at the Faculty of Medicine , KU Leuven , and leads the Laboratory of Lipid Metabolism and Cancer . He also directs the Lipometrix - KU Leuven Lipidomics Core Facility and the Subdivision JS - LISCO-BIOMED , while being a member of the LISCO - KU Leuven Institute for Single Cell Omics and LKI - KU Leuven Cancer Institute . Research Focus: Lipid metabolism in cancer and neurodegenerative diseases Leadership: Head of multiple research units Teaching: Courses on cancer treatment and biomedical research methods Research Interests span lipidomics, cancer metabolism, and neurodegeneration, with projects targeting lipid pathways in prostate, pancreatic, and liver cancers. His recent publications in top journals demonstrate translational applications of lipid metabolism research. Projects include: PRORUST (2025-2028): Exploiting lipid metabolism in prostate cancer Immunolipidomics (2025-2027): Developing lipid-targeted pancreatic cancer therapies CK2-MLX Pathway (2024-2028): Preventing liver cancer through metabolic intervention GRAN'PA (2025-2029): Investigating lipid homeostasis in neurodegenerative diseases Technical Innovations focus on enhancing mass spectrometry imaging resolution. His teaching portfolio includes courses on cancer treatment, lipid metabolism in health, and biomedical research methods.

• Lipid Metabolism
• Cancer Biology
• Neurodegenerative Diseases
• +۳ مورد دیگر

Dimitri De Bundel serves as Senior Lecturer at Vrije Universiteit Brussel's Faculty of Medicine and Pharmacy, where he leads research in the Experimental Pharmacology group. His work integrates behavioural, neurochemical, and electrophysiological methodologies to develop precision pharmacology interventions targeting memory and mood dysfunction in neurological and psychiatric disorders. His academic foundation includes a Pharmacy degree (summa cum laude, 2004) and PhD in Pharmaceutical Sciences (2009), both from VUB. Postdoctoral training followed at Karolinska Institutet (Sweden, 2009-2011) and Institut Génomique Fonctionelle (France, 2011-2014). Research focuses on seizure mechanisms, anticonvulsant development, ghrelin receptor function, and insulin's role in spatial memory. Current investigations explore psilocybin for Alzheimer's disease, ADHD medication safety during pregnancy, and noradrenergic modulation of contextual memory through hippocampal astrocyte receptors. Recent publications reveal strong interdisciplinary trends in CNS drug innovation, particularly photopharmacology applications for epilepsy and Alzheimer's disease, alongside advanced metabolomics techniques for brain tissue analysis. Scientific recognition includes: Hugo d'Haenen Award (2015) for contributions to biological psychiatry and serotonin research Les Grandes Avancées en Biologie-Santé du Pôle RABELAIS (2017) De Bundel actively mentors graduate students and secures major research funding, currently leading projects including ANI409 (psilocybin for Alzheimer's), FWOSB173 (ADHD medication outcomes), and FWOTM1217 (noradrenergic memory modulation). His collaborative work spans 33 projects including HERC66 (3D-CELLMAP) and OZR4299 (bilateral PhD cooperation). As a core member of VUB's Experimental Pharmacology group, he employs microdialysis, chemogenetics, and electrophysiology to study brain function while developing novel therapeutics for neurological disorders through precision targeting of neural circuits.

• Neuropharmacology
• Epilepsy
• Memory Disorders
• +۵ مورد دیگر

Prof. Dieter De Witte serves as a Professor at Ghent University, dedicating 50% of his time to the Internet Technology and Data Science Lab (IDLab) while simultaneously contributing 50% to the Royal Museums of Fine Arts Belgium (RMFAB) in Brussels through a FED-tWIN mandate from Belspo. At RMFAB, he spearheads the strategic overhaul of digital infrastructure toward FAIR-compliant and data-driven systems, while at Ghent University he collaborates with Prof. Steven Verstockt on applied AI projects across heritage, mental healthcare, and education domains. His academic foundation includes a Master's in Engineering Physics from Ghent University (2008) followed by doctoral research on Big Data technologies and FAIR data for life sciences. Prior to returning to academia in 2021, he gained industry experience as an AI consultant and team lead at Telenet and Ordina. De Witte's research centers on AI-driven transformation of cultural heritage through FAIR data publication , collection enrichment , and intuitive querying interfaces . His technical expertise spans multimodal algorithms, image segmentation, pose estimation, large language models (LLMs), and semantic technologies including SPARQL and IIIF. Current projects focus on human-in-the-loop AI systems that combine diverse AI building blocks for practical heritage applications. Analysis of his 15 most recent publications reveals a clear trajectory from early bioinformatics work (2007-2018) on genomic motif discovery and life sciences data infrastructure toward contemporary cultural heritage applications (2023-2024). Recent outputs demonstrate innovative fusion of pose estimation, linked data frameworks, and multimodal AI for museum contexts, highlighting increasing specialization in AI enrichment of digital collections while maintaining core expertise in FAIR data principles. His FED-tWIN grant enables critical knowledge transfer between academic research and cultural heritage institutions, supporting development of next-generation digital infrastructure at RMFAB. Current projects involve creating AI tools for intuitive collection exploration and systematic enrichment of heritage assets through advanced computational methods. De Witte operates within Ghent University's Internet Technology and Data Science Lab (IDLab), participating in interdisciplinary teams developing applied AI solutions. His work bridges technical innovation with practical implementation in cultural institutions, focusing on sustainable, interoperable systems that enhance public access to digital heritage collections through cutting-edge AI interaction paradigms.

• Artificial Intelligence
• Data Science
• FAIR Data
• +۳ مورد دیگر

Doris Vandeputte is a researcher in Clinical Sciences at Vrije Universiteit Brussel with an h-index of 13 and 4782 citations. Her research spans 21 publications from 2015-2024, demonstrating sustained scholarly activity in microbiome science. Her primary research interests include: Microbiota (100% research focus) Gastrointestinal Microbiome (99% research focus) Bacteroides (49% research focus) Firmicutes (37% research focus) Microbial Genome (25% research focus) Dr. Vandeputte's work examines the connections between gut microbial communities and human health conditions including ulcerative colitis, type 2 diabetes, and hormonal regulation. Her recent publications reveal a strong emphasis on translating microbiome findings into clinical applications, particularly regarding bacterial modulators of disease processes. Current major projects include: EU690: CoRe Defense (2025-2030) - Fortifying gut microbiota colonization resistance against intestinal infections OZR4397 (2025-2029) - High throughput screening for narrow-range anti-Campylobacter compounds Her research has generated significant attention, with publications appearing in high-impact journals including Endocrinology, Gut Microbes, Diabetes, and Microbiome, and receiving citations across multiple platforms.

• Microbiota
• Gastrointestinal Microbiome
• Bacteroides
• +۳ مورد دیگر

Samuel Pontrelli is an assistant professor at KU Leuven's Department of Biology and group leader at the VIB-KU Leuven Center for Microbiology. His research focuses on uncovering biochemical mechanisms of microbial carbon sequestration in marine environments, combining high-throughput metabolomics, enzyme assays, and wet-lab experiments. He holds affiliations with both the Faculty of Science and VIB's Center for Microbiology. Pontrelli's research interests center on microbial carbon capture and metabolism. His lab investigates how marine microbes transform carbon dioxide into stable dissolved organic carbon (DOC) through enzymatic activity and community-level interactions. Key projects include High-throughput metabolomics couples with enzyme assays to evaluate microbial metabolic interactions (2025-2029) and Stability incurred by enzymatic diversification (2025-2030), both as promotor. Marine carbon cycling Microbial community dynamics Enzymology Metabolomics Biochemical interactions Carbon sequestration His 15 most recent publications (2021-2025) demonstrate expertise in microbial metabolomics, polysaccharide degradation, and DOC stabilization mechanisms. Articles appear in journals like Nature Communications , Science Advances , and PNAS . As of 2025, his lab is newly established at KU Leuven's Arenberg campus.

• Microbiology
• Metabolomics
• Microbial Carbon capture
• +۳ مورد دیگر

Sarah-Maria Fendt is a Professor of Oncology at KU Leuven and Principal Investigator at the VIB Center for Cancer Biology. She serves as Head of the Laboratory of Cellular Metabolism and Metabolic Regulation and holds multiple leadership positions including membership in the Council of the Faculty of Medicine, the Council of the Department of Oncology, and the Research Council. Her primary research focuses on understanding the role of metabolism in driving cancer metastasis formation and defining metabolic regulation principles that enable cancer cell plasticity and heterogeneity. Dr. Fendt's lab applies cutting-edge single cell and spatial multi-omics technologies to study the interplay between cancer cells and their metabolic environment using pre-clinical mouse models and patient samples. Her research is funded by multiple national and international grants, including recent projects on metabolic vulnerabilities in acute myeloid leukemia, single-cell resolution in mass spectrometry imaging, and metabolic changes in metastatic liver. Dr. Fendt's publication record demonstrates significant contributions to cancer metabolism research, with recent articles in top journals including Nature, Nature Cancer, and Cell Reports. Her work reveals how metabolic adaptations drive metastasis through mechanisms including aspartate signaling, lipid metabolism, and metabolite-induced immune suppression. She has established herself as a leader in translating metabolic discoveries into potential therapeutic approaches. EMBO Gold Medal (2020) EMBO member (since 2022) Francqui-Collen prize (2023) 51st Léopold Griffuel award (2023) AACR award for Outstanding Achievement in Basic Cancer Research (2024) Dr. Fendt actively mentors the next generation of cancer researchers, with several students and postdocs presenting their work at international conferences. She recently completed a sabbatical at Peter MacCallum Cancer Centre in Australia working with Mark Dawson's laboratory. Her lab is a member of multiple research centers including the VIB-KU Leuven Center for Cancer Biology, LISCO (KU Leuven Institute for Single Cell Omics), and LKI (KU Leuven Cancer Institute).

• Cancer Metabolism
• Metastasis Biology
• Cellular Metabolism
• +۴ مورد دیگر

Luc De Vuyst is a Professor at the Department of Bio-engineering Sciences, Vrije Universiteit Brussel (VUB). His research focuses on fermentation processes, microbial diversity analysis, and metabolic modeling in food microbiology. Key research areas: Fermentation, Lactic/Acetic Acid Bacteria, Food Microbiology His recent work explores sourdough bread's impact on appetite regulation, metagenomics of cheese and rice vinegar fermentation, and microbial ester production dynamics. Studies utilize advanced techniques like HPLC, GC-MS, and metagenetic sequencing. Scientific awards include the Danone Leerstoel Coordinator role (1996) and recognition in the Institut Yoplait International Competition (1998). He has supervised numerous Master's theses on topics like sourdough microbiota and cheese fermentation.

• Fermentation
• Lactic Acid Bacteria
• Acetic Acid Bacteria
• +۵ مورد دیگر

Peter Dawyndt is a Professor in the Department of Applied Mathematics, Computer Science and Statistics at Ghent University's Faculty of Sciences, where he heads the Computational Biology Lab. His research bridges computer science and life sciences through interdisciplinary work on computational applications for (meta)genomics, (meta)proteomics, and educational data mining. The lab actively develops the Unipept platform for metaproteomics biodiversity analysis and the Dodona platform for programming education, demonstrating dual expertise in biological data science and educational technology. His research interests encompass computational biology, bioinformatics, and educational data mining with specific focus on metagenomics, metaproteomics, metatranscriptomics, and data visualization for life sciences applications, alongside learning analytics and educational technology for computer science education. The Unipept platform enables taxonomic analysis of metaproteome samples through tryptic peptide biomarkers, while the Dodona ecosystem includes tools like Dolos for plagiarism detection and Blink for Scratch debugging, all supporting active learning in coding education. Analysis of his 2023-2025 publications reveals two equally prominent research thrusts: advancement of bioinformatics tools (e.g., Unipept's expansion to non-tryptic peptides and metabolic pathway visualization) and innovation in educational technology (e.g., LLM applications for CS1 education and automated code review systems). This dual trajectory highlights his commitment to both fundamental biological discovery and transformative educational practices in computing. No scientific awards were documented in the provided source materials. While specific student advising details and grant information were not explicitly stated, his leadership of the Computational Biology Lab and extensive publication record suggest active mentorship of graduate students and researchers in developing computational tools for biological and educational applications. The Computational Biology Lab operates as an integrated team developing the Unipept and Dodona platform ecosystems. Current projects include enhancing metaproteomics analysis capabilities through missed cleavage support and expanding educational tools for plagiarism detection and virtual co-teaching, reflecting the lab's commitment to open-source software development at the computer science-life sciences education interface.

• Computational Biology
• Bioinformatics
• Computer Science
• +۷ مورد دیگر

Roland Devlieger is a Professor at the Faculty of Medicine, KU Leuven, affiliated with the Department of Development and Regeneration and the Unit Woman and Child at UZ Leuven. He serves as a member of the Council of the Faculty of Medicine and the Council of the Department of Development and Regeneration, and is associated with Leuven.IRD - KU Leuven Institute for Rare Diseases. His research spans multiple critical areas in maternal-fetal medicine, with particular focus on pregnancy interventions , endocrine disruptors , obesity management in pregnancy, and bariatric surgery outcomes . His work addresses both metabolic and surgical aspects of high-risk pregnancies, with significant emphasis on lifestyle modifications and their impact on maternal and fetal outcomes. Analysis of his recent publications reveals a strong trend toward clinical trials and cohort studies addressing complex pregnancy conditions. His work demonstrates expertise in bariatric surgery pregnancies , fetal interventions for conditions like spina bifida, and hemolytic disease management . The publications reflect interdisciplinary collaboration across obstetrics, endocrinology, nutrition, and fetal surgery. Professor Devlieger leads multiple significant research projects including 'New interventions to improve maternal and fetal (metabolic) outcome' (2025-2030) as Promotor, 'Pregnancy and early parenthood: the impact of mental health, endocrine disruptors and lifestyle interventions' (2024-2028) as Co-promotor, and several other major studies focused on pregnancy outcomes after bariatric surgery, endocrine disruptors, and lifestyle interventions. His teaching portfolio includes numerous courses in obstetrics and gynecology, with specific focus on lifestyle interventions for young families, specialized midwifery care, and clinical skills development in gynecology and obstetrics. His educational contributions reflect his clinical and research expertise in maternal-fetal medicine.

• Maternal-Fetal Medicine
• Pregnancy Interventions
• Endocrine Disruptors
• +۷ مورد دیگر

Bart Ghesquière is a Full Professor at the Department of Cellular and Molecular Medicine, Faculty of Medicine, KU Leuven, and heads the Metabolomics Expertise Center at the VIB-KU Leuven Center for Cancer Biology. He leads the Laboratory of Applied Mass Spectrometry (LAMaS) and serves as head of the Proteomics Core Facility at KU Leuven. His leadership extends to multiple research initiatives including membership in the VIB-KU Leuven Center for Cancer Biology, LISCO (KU Leuven Institute for Single Cell Omics), and LKI (KU Leuven Cancer Institute. He also participates in institutional governance as a member of the Council of the Faculty of Medicine and the Council of the Department of Cellular and Molecular Medicine. Dr. Ghesquière's research focuses on metabolomics, mass spectrometry, biochemistry, and stable isotope tracing. His work centers on tracer metabolomics, which provides comprehensive insights into metabolic pathways ('Google Maps of Biochemistry'), revealing both the activity and interconnectivity of biochemical pathways across diverse biological contexts. His laboratory develops novel mass spectrometry-based technologies while applying them to study metabolic disorders and syndromes, with particular emphasis on congenital disorders of glycosylation, mitochondrial disorders, and organ metabolism during transplantation procedures. His scientific contributions include the development of innovative tools like TraVis Pies for stable isotope metabolomics interpretation and significant discoveries in metabolic pathways related to glycosylation disorders, kidney perfusion, and cellular metabolism under stress conditions. His work has been published in high-impact journals including Nature, Cell Reports, and American Journal of Human Genetics. Orloff Science award (received during his work at NIH) Dr. Ghesquière currently leads a team of 11 researchers including a project manager, expert technicians, senior postdoctoral scientists, data analysts, and PhD students. He serves as promotor for two PhD students and co-promotor for three others. His research is supported by multiple ongoing projects including studies on de novo serine biosynthesis in obesity-induced cardiomyocyte dysfunction, short chain fatty acids in hepatic lipid metabolism, and nuclear metabolism in cancer cells under hypoxia. His laboratory provides metabolomics services to research groups while developing novel technologies and biological applications. The Metabolomics Expertise Center under Dr. Ghesquière's leadership functions as both a service facility for metabolomics-oriented research groups and an innovative research hub developing cutting-edge technologies in tracer metabolomics. His team has developed specialized software like MAIMS for metabolic tracer analysis and continues to advance hardware and methodology in the field. The laboratory maintains strong collaborations across multiple disciplines, particularly in cancer biology, transplantation medicine, and rare metabolic disorders.

• metabolomics
• mass spectrometry
• biochemistry
• +۶ مورد دیگر

Professor Bart De Moor is a full professor at the KU Leuven Faculty of Engineering Sciences, affiliated with the Department of Electrical Engineering (ESAT) and the STADIUS Center for Dynamic Systems, Signal Processing, and Data Analysis. His research spans mathematical engineering, system theory, and biomedical data science, with significant contributions to Machine Learning Medical AI Time Series Analysis High-Dimensional Data Optimization underpinned by an ERC Advanced Grant and the Order of the Crown (2025). His recent work includes AI-driven clinical decision support systems ( BJOG , 2025), spatial omics pipelines for pancreatic cancer ( Cancer Research , 2025), and energy demand forecasting ( Applied Energy , 2025). He has supervised over 93 PhD students and founded 9 spin-offs, including Health House and Athumi .

• Mathematical Engineering
• System Theory and Control
• Numerical Optimization
• +۴ مورد دیگر

Prof. Dr. Wanda Guedens is a Full Professor at Hasselt University's Faculty of Sciences, leading the Biomolecule Design Group (BDG) and serving as Vice Rector for Education. Her research focuses on designing protein-based biomaterials for advanced healthcare, including hydrogels, nanobodies, and biosensors. She holds a PhD in Chemistry (1999) and has supervised 8 PhD students in areas like cancer diagnostics and biomaterials. Her work integrates biochemistry, materials science, and metabolomics, with notable contributions to early cancer detection via nanobodies and hydrogel-based drug delivery systems. She pioneered gamification tools like the GAPc project to enhance chemistry education and transition to higher education. Her interdisciplinary approach spans biomaterials development, metabolic profiling of diseases (e.g., lung cancer, diabetes), and innovative bioconjugation techniques. As Vice Rector, she oversees educational strategies at Hasselt University, emphasizing active learning and student success. Her lab, BDG, collaborates on 13 research projects, advancing materials chemistry and biofunctionalized surfaces for medical applications.

• Biomaterials
• Bio-organic chemistry
• Protein functionalization
• +۵ مورد دیگر

Nagabushana Aswatha Reddy is a researcher affiliated with the Faculty of Sciences , focusing on mitochondrial dysfunction and its links to metabolic disorders. His work bridges metabolomics and biochemical pathways to address obesity, hypertrophy, and lipid metabolism. Key research areas: metabolomics, mitochondrial biology, and lipid metabolism Active participant in international workshops and conferences His 2018 publication revealed autophagy-dependent lipolysis in adipocytes, while a 2014 article provided foundational insights into mitochondrial metabolic pathways. These works highlight his expertise in mitochondrial uncoupling, enzyme activity, and oxidative phosphorylation. Reddy has presented research at events like the PhD Students Day - From Bacteria to Human (2014) and the 10th Training Course on Programmed Cell Death (2013), demonstrating cross-disciplinary collaboration in cell death and metabolic regulation studies.

• Metabolomics
• Biochemical Pathways
• Mitochondrial Dysfunction
• +۳ مورد دیگر

Jeroen Raes is a Professor at KU Leuven and Head of the Laboratory of Molecular Bacteriology (Rega Institute) within the Department of Microbiology, Immunology and Transplantation. He also serves as Head of the Divisie Bacteriologie – Rega and is a member of the VIB-KU Leuven Center for Microbiology, Leuven One Health Institute, and LISCO (KU Leuven Institute for Single Cell Omics). His roles include Promotor and Co-promotor in multiple research projects addressing gut microbiome resilience, tumor-resident bacteria in colorectal cancer, and the Gut-Immune-Brain axis in inflammatory bowel disease. His research focuses on gut flora, microbiome dynamics, bioinformatics, metagenomics, and microbiology. Notable projects investigate microbiota modulation strategies in chronic diseases, environmental exposome impacts on gut health, and the role of microbial interactions in inflammation and cancer progression. He collaborates widely in both academic and clinical settings, including leadership roles in trials like the halted FMT trial in ulcerative colitis (CONQUERESS) and the PHOENIX series exploring exercise impacts post-transplantation. Recent publications emphasize virome dynamics in inflammatory conditions, dietary effects on microbiome composition, and analytical tools for metabolomics (e.g., TARDIS). His work bridges basic science and clinical applications, with studies on microbiome-based diagnostics and therapies for cancer, neurodegenerative diseases, and autoimmune disorders. Despite no listed scientific awards, his contributions to understanding microbiome roles in health and disease are significant. He teaches courses in Omics Techniques, Bioinformatics, and advanced microbiology topics, including 'Hot Topics in Gastroenterology' and 'Advanced Microbiology.' His advisory roles in the Faculty of Medicine and Departmental Council reflect his institutional leadership. Collaborative efforts with the ImmunAID consortium and Human Microbiome Action Consortium highlight his commitment to large-scale, multidisciplinary research initiatives. Research infrastructure includes the Rega Institute and VIB-KU Leuven Center, where he leads projects integrating microbiome analysis with environmental and clinical data. Ongoing work explores microbiome influences on stress reactivity, anorexia nervosa pathogenesis, and the exposome's role in chronic inflammation (FLEXiGUT project).

• Microbiology
• Immunology
• Transplantation Medicine
• +۳ مورد دیگر